Search
Could This Precision Medicine Approach Help Patients Delay Dementia?
Combining genetic risk with cardiovascular disease risk factors — such as high LDL cholesterol, obesity, and hypertension — may predict who is more likely to develop dementia, according to a new study led by UC San Francisco.New Treatment Framework for Anti-Amyloid Therapies Developed by UCSF-led Alzheimer’s Association Consortium
A breakthrough treatment in the fight against Alzheimer’s disease is a class of therapies called anti-amyloid antibodies (anti-A?). These monoclonal antibodies – proteins made in a laboratory intended to stimulate the immune system – have been shown to slow the progression of the disease by targeting amyloid plaques in the brain that are characteristic of Alzheimer’s.Memory and Cognitive Disorders: The Latest Prevention, Diagnostic and Treatment Strategies
In this webinar, behavioral neurologist Bruce Miller, MD, director of the UCSF Memory and Aging Center, discusses Alzheimer’s disease (AD), frontotemporal dementia (FTD), Parkinson’s disease dementia (PDD) and dementia with Lewy body disease (DLB).Why Do Some Brain Regions Resist Alzheimer’s?
UCSF researchers create "Google Maps” for how tau moves in the brain of Alzheimer’s patients.UCSF Health Leads Statewide Efforts to Improve Dementia Care, Diagnosis
UCSF Health provides innovative tools, guidance to improve access and awareness related to brain health and dementia detection.Tailored Deep Brain Stimulation Improves Walking in Parkinson’s Disease
UCSF researchers develop first-of-its-kind measure of gait performance, allowing researchers to fine tune electrical pulses to the neural network.Stephen Hauser Wins Breakthrough Prize for Role in Redefining MS
Neuro-immunologist Stephen Hauser, MD, whose maverick thinking transformed the treatment landscape for patients with multiple sclerosis (MS), has received the 2025 Breakthrough Prize in Life Sciences.UCSF Stroke Clinic
The stroke clinic provides expert consultations and outpatient care to patients who are at risk of a stroke or have had a stroke due to neurovascular conditions.This New Treatment Can Adjust to Parkinson's Symptoms in Real Time
People with Parkinson’s disease have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.How a Paralyzed Man Moved a Robotic Arm Using a Brain-Computer Interface
Researchers at UC San Francisco have enabled a man who is paralyzed to control a robotic arm that receives signals from his brain via a computer.Enhancing MRI with AI to Improve Diagnosis of Brain Disorders
At the intersection of AI and medical science, there is growing interest in using machine learning to enhance imaging data captured by magnetic resonance imaging (MRI) technology.Acute Stroke Transfer Guide for Providers
Information resources for Acute Stroke Transfer Guide for Providers.Lo-Res to Hi-Res, A Better way to Pinpoint Where Seizures Begin
For most people with epilepsy, seizures can be controlled with anti-seizure medications. But for about a third of epilepsy patients, medications fail to halt their seizures and surgery may be necessary to remove or disconnect damaged brain tissue responsible for causing seizures.Delayed REM Sleep Could Be an Early Sign of Alzheimer’s
Scientists have recently shown that both the quality and the amount of sleep we get may influence our risk of developing Alzheimer’s disease.Poor Sleep in Midlife Is Linked to Faster Brain Atrophy
For adults in midlife, difficulty getting to sleep and waking up too early may accelerate brain atrophy that is associated with dementia.Neuromuscular Clinic Referral Guide
Primary Care Predicaments: Myopathies, Neuropathies & Neuromuscular Conditions, Oh My!
From ALS to myasthenia gravis to Guillain-Barré syndrome, potentially aggressive neuromuscular disorders can present with a range of nebulous symptoms.New Discovery Reveals Pathway to Modulate Scarring in Spinal Cord Injury
After a spinal cord injury, nearby cells quickly rush to action, forming protective scar tissue around the damaged area to stabilize and protect itForecasting May Help People with Epilepsy Predict Their Seizures
UCSF team discovers brain activity patterns that foreshadow seizures up to 24 hours before they occur.ER Visit Leads to Moyamoya Disease Diagnosis and Personalized Treatment Plan: UCSF Case Study
A 47-year-old woman came to the UCSF emergency department with acute slurred speech along with left-sided facial droop and left-sided numbness, suggesting a stroke. Vessel imaging showed bilateral obstructive arteriopathy, an indication of moyamoya disease.Life-Changing Care for Untreated Spinal Muscular Atrophy: UCSF Case Study
An adult man with spinal muscular atrophy (SMA) had been born with limb weakness that progressed to respiratory muscle weakness. Though able to sit independently since childhood, he was never able to walk. Due to the high cost of medication in his home country, he was unable to receive treatment, so he moved to the United States at age 36 to seek therapy for his SMA.Inpatient Infusion Therapy for Refractory Headaches: UCSF Case Study
The first center of its kind on the West Coast, the UCSF Headache Center provides patients with comprehensive care to relieve the most debilitating headaches. This includes inpatient treatment for people with severe unremitting or recurring headaches for whom first-line therapies have failed.Improving Measurement of Parkinson’s Disease Severity with AI
Despite recent advancements in the treatment of Parkinson’s Disease, it remains a challenge to accurately measure the progression of symptoms in this neurological disorder.Interdisciplinary Vasculopathy Care
The UCSF Vasculopathy Clinic provides comprehensive, interdisciplinary care for patients with moyamoya disease, atherosclerosis and other conditions that cause intracranial vasculopathy.